RheaVita
Zwijnaarde
About RheaVita
RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products. The company technology integrates all freeze-drying process step unit operations in a continuous production line with the constant infeed of products and the concomitant outfeed of the dried product. Its manufacturing approach avoids scale-up issues, reduces cycle times, allows fast product development, reduces time-to-market, lowers production costs, makes use of smaller manufacturing installations, requires less clean room space, provides improved quality assurance (100% inspection with inherent potential for real-time-release) and leads to improved and uniform product quality and process uniformity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2021)
- Website: rheavita.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Mechanical Engineering, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/rheavita-120041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.